Jining Medical University, Jining, Shandong Province, China.
Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):2002-2010. doi: 10.26355/eurrev_202303_31566.
The platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR), which can be easily measured from whole blood counts, are composite reflections of significant inflammatory response pathways. However, the relationship between PLR and NLR in patients with ovarian endometriosis is only partially supported by clinical evidence. This study aimed at identifying useful markers for early diagnosis by examining the relationship between PLR and NLR in patients with ovarian endometriosis.
Between June 2015 and December 2022, we gathered clinical data of 10,458 endometriosis patients who visited the Gynecology Division of the Affiliated Hospital of Jining Medical University. All statistical analyses were performed using the R statistical package.
The results of the univariate analysis, smoothed curve fitting, multiple regression analysis, and subgroup analysis revealed that NLR was always positively correlated with PLR. Further analysis based on the curve fitting threshold effect revealed a significant positive correlation between NLR and PLR when NLR < 2.07 (β: 34.49). Furthermore, when NLR > 2.07, there was a significant positive correlation between NLR and PLR (β: 16.93).
The finding that NLR and PLR have a positive correlation confirms that inflammation plays a role in the pathogenesis of ovarian endometriosis. Therefore, PLR and NLR could be used as new biomarkers for the diagnosis of endometriosis.
血小板-淋巴细胞比值(PLR)和中性粒细胞-淋巴细胞比值(NLR)可通过全血细胞计数轻松测量,是反映重要炎症反应途径的综合指标。然而,PLR 和 NLR 在卵巢子宫内膜异位症患者中的关系仅得到部分临床证据的支持。本研究旨在通过检查卵巢子宫内膜异位症患者中 PLR 和 NLR 之间的关系,确定有用的早期诊断标志物。
在 2015 年 6 月至 2022 年 12 月期间,我们收集了 10458 名在济宁医学院附属医院妇科就诊的子宫内膜异位症患者的临床数据。所有统计分析均使用 R 统计软件包进行。
单因素分析、平滑曲线拟合、多元回归分析和亚组分析的结果表明,NLR 始终与 PLR 呈正相关。基于曲线拟合阈值效应的进一步分析表明,当 NLR<2.07 时(β:34.49),NLR 和 PLR 之间存在显著的正相关关系。此外,当 NLR>2.07 时,NLR 和 PLR 之间存在显著的正相关关系(β:16.93)。
NLR 和 PLR 呈正相关的发现证实了炎症在卵巢子宫内膜异位症发病机制中的作用。因此,PLR 和 NLR 可以作为子宫内膜异位症诊断的新标志物。